Treatment of CML in pediatric patients: Should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy?

Sti 571 ◽

Line Therapy

Second Allogeneic Hematopoietic Cell Transplant Is a Successful Salvage Modality for Pediatric Patients Who Relapse after First Transplant

10.1016/j.bbmt.2019.12.586 ◽

2020 ◽

Vol 26 (3) ◽

pp. S85-S86

Author(s):

Akshay Sharma ◽

Sujuan Huang ◽

Aimee C Talleur ◽

Amr Qudeimat ◽

Ashok Srinivasan ◽

...

Keyword(s):

Pediatric Patients ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Faculty Opinions recommendation of A single center, open-label trial of isavuconazole prophylaxis against invasive fungal infection in patients undergoing allogeneic hematopoietic cell transplant (HCT).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.737422328.793571687 ◽

2020 ◽

Author(s):

Livio Pagano

Keyword(s):

Fungal Infection ◽

Invasive Fungal Infection ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Single Center ◽

Open Label ◽

Open Label Trial

Treatment with Foscarnet after Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Is Associated with Long-Term Loss of Renal Function

10.1016/j.bbmt.2020.05.007 ◽

2020 ◽

Vol 26 (9) ◽

pp. 1597-1606

Author(s):

Gena G. Foster ◽

Michael J. Grant ◽

Samantha M. Thomas ◽

Blake Cameron ◽

Doug Raiff ◽

...

Keyword(s):

Renal Function ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Prospective Randomized Study of Advance Directives in Allogeneic Hematopoietic Cell Transplant Recipients

Transplantation and Cellular Therapy ◽

10.1016/j.jtct.2021.03.030 ◽

2021 ◽

Author(s):

Irena T Tan ◽

Vandana Sundaram ◽

Yvette Ramirez ◽

Sarah Burnash ◽

D. Kate Tierney ◽

...

Keyword(s):

Advance Directives ◽

Randomized Study ◽

Hematopoietic Cell ◽

Prospective Randomized Study ◽

Cell Transplant ◽

Transplant Recipients ◽

Impact of Letermovir Prophylaxis on Voriconazole Exposure in Allogeneic Hematopoietic Cell Transplant Recipients

Transplantation and Cellular Therapy ◽

10.1016/s2666-6367(21)00158-5 ◽

2021 ◽

Vol 27 (3) ◽

pp. S124

Author(s):

Issam S. Hamadeh ◽

Michael R. Grunwald ◽

Allison Martin ◽

Jai N. Patel ◽

Alexandra Wolff ◽

...

Keyword(s):

Hematopoietic Cell ◽

Cell Transplant ◽

Transplant Recipients ◽

Dynamics of Epstein–Barr virus on post‐transplant lymphoproliferative disorders after antithymocyte globulin‐conditioned allogeneic hematopoietic cell transplant

Transplant Infectious Disease ◽

10.1111/tid.13719 ◽

2021 ◽

Author(s):

Julian Lindsay ◽

Jad Othman ◽

Michelle K. Yong ◽

David Ritchie ◽

Lynette Chee ◽

...

Keyword(s):

Antithymocyte Globulin ◽

Epstein Barr Virus ◽

Lymphoproliferative Disorders ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Post Transplant ◽

Barr Virus ◽

Epstein Barr

Genomic and Proteomic Analysis of Allogeneic Hematopoietic Cell Transplant Outcome. Seeking Greater Understanding the Pathogenesis of GVHD and Mortality

10.1016/j.bbmt.2008.12.500 ◽

2009 ◽

Vol 15 (1) ◽

pp. e1-e7 ◽

Cited By ~ 3

Author(s):

John A. Hansen

Keyword(s):

Proteomic Analysis ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Transplant Outcome ◽

Focal nodular hyperplasia in pediatric allogeneic hematopoietic cell transplant: case series

Bone Marrow Transplantation ◽

10.1038/bmt.2009.336 ◽

2010 ◽

Vol 45 (8) ◽

pp. 1357-1359 ◽

Cited By ~ 15

Author(s):

L Anderson ◽

D Gregg ◽

D Margolis ◽

J Casper ◽

J Talano

Keyword(s):

Focal Nodular Hyperplasia ◽

Case Series ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Nodular Hyperplasia

High Risk Allogeneic Hematopoietic Cell Transplant (HCT) Patients with Any Level of Cytomegalovirus (CMV) Viremia Should Be Treated with Antiviral Therapy to Prevent Serious CMV Disease

10.1016/j.bbmt.2012.11.463 ◽

2013 ◽

Vol 19 (2) ◽

pp. S312

Author(s):

Lena Winestone ◽

Rajni Agarwal ◽

Kenneth I. Weinberg ◽

Matthew Porteus ◽

Jennifer Reikes Willert ◽

...

Keyword(s):

High Risk ◽

Antiviral Therapy ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Cmv Disease

Replicated Risk Index of Patient Functional Status Prior to Allogeneic Hematopoietic Cell Transplant Predicts Healthcare Utilization and Survival

Transplantation and Cellular Therapy ◽

10.1016/j.jtct.2021.06.021 ◽

2021 ◽

Author(s):

Megan M. Herr ◽

Shabnam Rehman ◽

Yali Zhang ◽

Christine M. Ho ◽

George L. Chen ◽

...

Keyword(s):

Functional Status ◽

Healthcare Utilization ◽

Risk Index ◽

Hematopoietic Cell ◽

Cell Transplant ◽